PAD4 regulates proliferation of multipotent haematopoietic cells by controlling c-myc expression

Nature Communications

Volumn 4, Issue , 2013, Pages

  Nakashima, Katsuhiko ^a   Arai, Satoko ^a   Suzuki, Akari ^b   Nariai, Yuko ^c   Urano, Takeshi ^c   Nakayama, Manabu ^d   Ohara, Osamu ^d   Yamamura, Ken Ichi ^e   Yamamoto, Kazuhiko ^b   Miyazaki, Toru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^d KAZUSA DNA RESEARCH INSTITUTE   (Japan)

^e KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; HISTONE DEACETYLASE 1; HISTONE H3; LYMPHOID ENHANCER FACTOR 1; MYC PROTEIN; PEPTIDYLARGININE DEIMINASE 4; UNCLASSIFIED DRUG;

CATALYSIS; CELL ORGANELLE; ENZYME ACTIVITY; GENE EXPRESSION; PROTEIN; RODENT; WILD POPULATION;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CATALYSIS; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; HEMATOPOIETIC CELL; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM;

MUS;

EID: 84878566177     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2862     Document Type: Article

References (41)

1. Vossenaar, E. R., Zendman, A. J., van Venrooij, W. J. & Pruijn, G. J. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 25, 1106-1118 (2003). (Pubitemid 37411770)
2. Arita, K. et al. Structural basis for Ca(2)-induced activation of human PAD4. Nat. Struct. Mol. Biol. 11, 777-783 (2004). (Pubitemid 39014504)
3. Suzuki, A., Yamada, R. & Yamamoto, K. Citrullination by peptidylarginine deiminase in rheumatoid arthritis. Ann. N. Y. Acad. Sci. 1108, 323-339 (2007). (Pubitemid 47528745)
4. Gyorgy, B., Toth, E., Tarcsa, E., Falus, A. & Buzas, E. I. Citrullination: a posttranslational modification in health and disease. Int. J. Biochem. Cell Biol. 38, 1662-1677 (2006). (Pubitemid 43947646)
5. Hagiwara, T., Nakashima, K., Hirano, H., Senshu, T. & Yamada, M. Deimination of arginine residues in nucleophosmin/B23 and histones in HL-60 granulocytes. Biochem. Biophys. Res. Commun. 290, 979-983 (2002). (Pubitemid 34687458)
6. Nakashima, K., Hagiwara, T. & Yamada, M. Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes. J. Biol. Chem. 277, 49562-49568 (2002). (Pubitemid 36014395)
7. Wang, Y. et al. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 306, 279-283 (2004). (Pubitemid 39336873)
8. Cuthbert, G. L. et al. Histone deimination antagonizes arginine methylation. Cell 118, 545-553 (2004). (Pubitemid 39179708)
9. Li, P. et al. Regulation of p53 target gene expression by peptidylarginine deiminase 4. Mol. Cell. Biol. 28, 4745-4758 (2008).
10. Yao, H. et al. Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis. J. Biol. Chem. 283, 20060-20068 (2008).
11. Denis, H. et al. Functional connection between deimination and deacetylation of histones. Mol. Cell. Biol. 29, 4982-4993 (2009).
12. Li, P. et al. Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression. Oncogene 29, 3153-3162 (2010).
13. Zhang, X. et al. Genome-wide analysis reveals PADI4 cooperates with Elk-1 to activate c-Fos expression in breast cancer cells. PLoS Genet. 7, e1002112 (2011).
14. Nakashima, K. et al. Molecular characterization of peptidylarginine deiminase in HL-60 cells induced by retinoic acid and 1alpha,25-dihydroxyvitamin D(3). J. Biol. Chem. 274, 27786-27792 (1999).
15. Vossenaar, E. R. et al. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann. Rheum. Dis. 63, 373-381 (2004). (Pubitemid 38453302)
16. Suzuki, A. et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat. Genet. 34, 395-402 (2003). (Pubitemid 36935332)
17. Jones, J. E., Causey, C. P., Knuckley, B., Slack-Noyes, J. L. & Thompson, P. R. Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential. Curr. Opin. Drug Discov. Devel. 12, 616-627 (2009).
18. Girbal-Neuhauser, E. et al. The epitopes targeted by the rheumatoid arthritisassociated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J. Immunol. 162, 585-594 (1999). (Pubitemid 29018970)
19. Schellekens, G. A., de Jong, B. A., van den Hoogen, F. H., van de Putte, L. B. & van Venrooij, W. J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J. Clin. Invest. 101, 273-281 (1998). (Pubitemid 28058927)
20. Wegner, N. et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol. Rev. 233, 34-54 (2010).
21. Wang, Y. et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J. Cell. Biol. 184, 205-213 (2009).
22. Li, P. et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med. 207, 1853-1862 (2010).
23. Chumanevich, A. A. et al. Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor. Am. J. Physiol. Gastrointest. Liver Physiol. 300, G929-G938 (2011).
24. Willis, V. C. et al. N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L- ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. J. Immunol. 186, 4396-4404 (2011).
25. Wang, Y. et al. Anticancer peptidylarginine deiminase (PAD) inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex 1 activity. J. Biol. Chem. 287, 25941-25953 (2012).
26. Hoffman, B., Amanullah, A., Shafarenko, M. & Liebermann, D. A. The protooncogene c-myc in hematopoietic development and leukemogenesis. Oncogene 21, 3414-3421 (2002). (Pubitemid 34587713)
27. Wilson, A. et al. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev. 18, 2747-2763 (2004). (Pubitemid 39507768)
28. Petropoulos, K. et al. A novel role for Lef-1, a central transcription mediator of Wnt signaling, in leukemogenesis. J. Exp. Med. 205, 515-522 (2008). (Pubitemid 351439299)
29. Wierstra, I. & Alves, J. The c-myc promoter: still MysterY and challenge. Adv. Cancer Res. 99, 113-333 (2008). (Pubitemid 350137254)
30. Billin, A. N., Thirlwell, H. & Ayer, D. E. Beta-catenin-histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator. Mol. Cell Biol. 20, 6882-6890 (2000).
31. Kiel, M. J. et al. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121, 1109-1121 (2005). (Pubitemid 40884400)
32. Thompson, B. J. et al. Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7. J. Exp. Med. 205, 1395-1408 (2008). (Pubitemid 351831495)
33. Thompson, P. R. & Fast, W. Histone citrullination by protein arginine deiminase: is arginine methylation a green light or a roadblock? ACS Chem. Biol. 1, 433-441 (2006).
34. Zhao, C. et al. Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 12, 528-541 (2007). (Pubitemid 350199070)
35. Reya, T. & Clevers, H. Wnt signalling in stem cells and cancer. Nature 434, 843-850 (2005). (Pubitemid 40558990)
36. Staal, F. J., Luis, T. C. & Tiemessen, M. M. WNT signalling in the immune system: WNT is spreading its wings. Nat. Rev. Immunol. 8, 581-593 (2008).
37. Dong, S., Zhang, Z. & Takahara, H. Estrogen-enhanced peptidylarginine deiminase type IV gene (PADI4) expression in MCF-7 cells is mediated by estrogen receptor-alpha-promoted transfactors activator protein-1, nuclear factor-Y, and Sp1. Mol. Endocrinol. 21, 1617-1629 (2007). (Pubitemid 47001086)
38. Tanikawa, C. et al. Regulation of protein Citrullination through p53/PADI4 network in DNA damage response. Cancer Res. 69, 8761-8769 (2009).
39. Tanikawa, C. et al. Regulation of histone modification and chromatin structure by the p53-PADI4 pathway. Nat. Commun. 3, 676 (2012).
40. Slack, J. L., Causey, C. P. & Thompson, P. R. Protein arginine deiminase 4: a target for an epigenetic cancer therapy. Cell Mol. Life Sci. 68, 709-720 (2011).
41. Li, Z. et al. Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias. Cancer Res. 69, 1109-1116 (2009).